Orgenesis and University of California, Davis sign partnership agreement for rollout of cell and gene therapy mobile processing units and labs throughout California Germantown, Maryland and Davis, California, US, June 7, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company&r.
Three babies have been born after receiving the world's first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health.